This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bone Metabolism Therapeutics Market To 2018 - Hyperparathyroidism Sector To Decline In The Absence Of New Product Launches And Increased Generic Erosion For Zemplar, Hectorol And Sensipar

Figure 6: Bone Metabolism Therapeutics Market, The US, Annual Cost of Treatment ($), 2002-2018 19

Figure 7: Bone Metabolism Therapeutics Market, The US, Treatment Usage Patterns (millions), 2002-2018 20

Figure 8: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, Revenue Forecasts ($bn), 2002-2018 22

Figure 9: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, by Geography, Revenue Forecasts ($bn), 2002-2018 23

Figure 10: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, Annual Cost of Treatment ($), 2002-2018 24

Figure 11: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, Treatment Usage Patterns (millions), 2002-2018 25

Figure 12: Bone Metabolism Therapeutics Market, Japan, Revenue Forecasts ($bn), 2002-2018 27

Figure 13: Bone Metabolism Therapeutics Market, Japan, Annual Cost of Treatment ($), 2002-2018 28

Figure 14: Bone Metabolism Therapeutics Market, Japan, Treatment Usage Patterns (millions), 2002-2018 29

Figure 15: Osteoporosis Therapeutics Market, Global, Revenue Forecasts ($bn), 2002-2018 31

Figure 16: Osteoporosis Therapeutics Market, Global, Revenue Analysis by Geography ($bn), 2002-2018 32

Figure 17: Osteoporosis Therapeutics Market, Global, Branded vs. Generic Share, 2010 and 2018 34

Figure 18: Osteoporosis Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2018 35

Figure 19: Osteoporosis Therapeutics Market, Global, Treatment Usage Patterns (millions), 2002-2018 36

Figure 20: Osteoporosis Therapeutics Market, Treatment Flow Algorithm 38

Figure 21: Osteoporosis, Market Drivers and Barriers 39

Figure 22: Paget's Disease of Bone Therapeutics Market, Global, Revenue Forecasts ($m), 2002-2018 41

Figure 23: Paget's Disease of Bone Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2002-2018 42

Figure 24: Paget's Disease of Bone Therapeutics Market, Global, Branded vs. Generic Share, 2010 and 2018 44

Figure 25: Paget's Disease of Bone Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2018 45

8 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs